PODCAST · science
The Onco'Zine Brief with Peter Hofland
by Peter Hofland
Peter Hofland, Ph.D. is the host of The Onco'Zine Brief, a radio show/podcast especially designed for the community of medical and healthcare professionals in oncology and hematology as well as cancer patients, their families, and caregivers. In the show, Hofland talks about the latest researcher, developments, and news in cancer and cancer treatment. They also interview physicians, world-renowned researchers, Key Opinion Leaders/Experts, and Key Stakeholders who share the common objective of preventing cancer, fostering a favorable environment for scientific research, and advocating for equal access to high-quality cancer treatment, and educate cancer patients and their friends and family.
Episodes
-
Developing a New Standard of Care Cancer Treatment with Photoimmunotherapy
In this episode of The Onco'Zine Brief, Peter Hofland talks with David M. Cognetti, MD, a Professor and Chair in the Department Head and Neck Surgery at Thomas Jefferson University Hospital in Philadelphia. Hofland and Cognetti talk about head and neck cancer and a novel treatment approach called...
-
Highlights from ASH: Conversations with Christopher Heery and Srdan Verstovsek
In this episode of The Onco'Zine Brief, Peter Hofland talks with two experts about their research and the impact the outcomes from these studies may have on the treatment of patients diagnosed with cancer. First, Hofland talks with Christopher Heery, MD. Dr Heery is a board-certified medical...
-
Highlights of ASH: Conversation about Multiple Myeloma with Thomas Martin and Monica Soni
In December 2022 the annual meeting of the American Society of Hematology took place in the vibrant city of New Orleans and brought together tens of thousands of participants from across the world to present and discuss the results of studies that ranged from initial hypothesis to…
more -
A Fantastic Voyage: From Magic Bullet to Antibody-drug Conjugate
In this –this episode of the Onco’Zine Brief, Peter Hofland is talking with Dr. Matthias Bucerius. Dr. Bucerius is Vice President and General Manager at MilliporeSigma. He is responsible for Contract Development and Manufacturing Organsation (CDMO) business of the company, leading a fully...
-
Mismatched Unrelated Donors: A Key to Erasing the Gap in Donor Availability in HCT
In this – the 100th episode of the Onco’Zine Brief, Peter Hofland, Ph.D. talks with Stephen Spellman, Vice President of Research and Senior Scientific Director of the Center for International Blood and Marrow Transplant Research at the National Marrow Donor Program/Be the Match. In the program...
-
Susanna Greer, Ph.D: Advancing Funding for Cutting-edge Cancer Research
In this edition of The Onco'Zine Brief, Peter Hofland, Ph.D, talks with Susanna F. Greer, Ph.D. the Chief Scientific Officer of the V Foundation. In her role, Dr. Greer is a visionary ambassador of the V Foundation, who works with the foundation’s Scientific Advisory Committee to steer funding to...
-
A Novel Approach to Advancing Breast Cancer Therapy
Despite availability of endocrine therapies for advanced or metastatic breast cancer, there remains a critical unmet need for more effective and convenient treatment options that improve both the patient experience and health outcomes. In today’s episode of The Onco’Zine Brief, Peter Hofland…
more -
ESMO 2022: Advances in the Treatment of Cancer
The annual congress of the European Society for Medical oncology or ESMO, is one of the most influential oncology meetings for clinicians, researchers, patient advocates, and healthcare industry representatives from all over the world. This year the annual Congress was held September 9 - 13, 2022...
-
Redefining the Rules of Cancer Treatment
Glioblastoma is an aggressive type of cancer that can occur in the brain or spinal cord. And while the disease can occur at any age, it tends to occur more often in older people. According to the American Cancer Society, United States, doctors diagnose between 12,000 and 14,000 patients with...
-
Valena Weight, MD - It's Time You Knew, The Power of Your Choices to Prevent Women's Cancer
Your annual doctors – or wellness visit may not be enough to prevent diseases like cancer. Daily health and lifestyle choices are the key to cancer prevention --but what are these choices? What is important? In "It’s Time you Knew’ - The Power of Your Choices to Prevent Women's Cancer", board...
-
Lynch Syndrome and Genetic Testing
After checking your cholesterol, hemoglobin A1C, and glucose level during your annual wellness check, your primary care phycisian says: 'It looks like we haven't done your genome. Why don't we do that?' How would you respond? If you have a genetic mutation that increases your risk for a treatable...
-
Marie E. Lamont: Lessons Learned during the COVID-19 Pandemic helps in Transforming Patient Access to Clinical Trials
Research out earlier this year confirms what many doctors had feared: Cancer screenings dropped significantly during the Covid-19 pandemic. The study, published in the February 2022 edition of Journal of the National Comprehensive Cancer Network, examined data from the Ontario Cancer Registry in...
-
ASCO 2021: Promising Data for a New Treatment Option of non-Hodgkin's Lymphoma
In this interview Paul Schmidt, co-host of The Onco'Zine Brief, asked Laurie H. Sehn, MD, Clinical Professor at the British Columbia Cancer Centre for Lymphoid Cancer in the Division of Medical Oncology at the University of British Columbia, Vancouver, BC, Canada, about new treatment options for...
-
SABCS 2021: Key Findings in Breast Cancer Research
In the past 30 years, the survival rate for breast cancer has improved by about 40%, one of the highest survival rates of any cancer. The increase in survival is, in part, due to advances in screening technology as well as improvement in cancer treatment and a better understanding of the biology…
more -
Working Tirelessly to Improve the Lives of Cancer Patients
Cancer remains the second leading cause of death in the world, and numbers are on the rise. To respond to the growing need for therapeutic solutions, much research is needed. In this episode of The Onco’Zine BriefPeter Hofland, Ph.D. talks with Susan Pandya, MD. Pandya is Vice President Clinical...
-
A Novel, First-in-class, Photodynamic Therapy for Patients with CTCL
In this episode of The Onco’Zine Brief Peter Hofland Ph.D. talks with Ellen J. Kim, MD. Kim is the Medical Director of the Dermatology Clinic at the Perelman Center for Advanced Medicine and Professor of Dermatology at the Hospital of the University of Pennsylvania. She is also the Lead Principal...
-
A Promising Treatment Option for Patients Diagnosed with Head-and-neck Cancer
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Eyal Talor, Ph.D., a clinical immunologist with over 25 years of hands-on management experience in clinical research and drug development. Talor joined CEL-SCI in October 1993 and was promoted to Chief Scientific Officer in...
-
PRECEDE: Transforming the Early Detection and Prevention of Pancreatic Cancer
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Diane Simeone, MD, the Committee Chair and Principal Investigator and Executive Committee Chair of the PRECEDE Consortium. Simeone is also the Laura and Isaac Perlmutter Professor of Surgery, Department of Surgery at NYU...
-
Advancements in the Treatment of Glioblastoma: "More Drug is Not Always Better"
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Nader Sanai, MD. Dr. Sanai is the director of the Ivy Brain Tumor Center and the director of neurosurgical oncology at the Barrow Neurological Institute in Phoenix, Arizona. In this episode of the program Hofland asked Sanai...
-
Antibody-drug Conjugates: Coming of Age
In this episode of The Onco’Zine Brief, developed in collaboration with ADC Review | Journal of Antibody-drug Conjugates (at www.ADCReview.com), Peter Hofland, Ph.D. talks with William (Bill) Newell, JD, Chief Executive Officer and a member of the Board of Directors of Sutro Biopharma...
-
Harnessing the Immune System to Fight Cancer: An Interview with Innate Pharma's Mondher Mahjoubi
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D., talks with Mondher Mahjoubi, MD, Chief Executive Officer and Chairman of the Executive Board of Innate Pharma, a clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through...
-
Shaping the Possibilities for Patients Everywhere: A Conversation with Zymeworks' Tony Polverino
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D talks with Tony Polverino, Ph.D. In September 2918 Polverino joined Zymeworks, a clinical-stage, biopharmaceutical company developing next-generation multifunctional biotherapeutics. He currently serves as the company's Executive Vice...
-
A New Way to Prevent Colon Cancer: A Conversation with Check-Cap's Yoav Kimchy, Ph.D.
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Yoav Kimchy, Ph.D. Kimchy has more than 20 years of experience in the development and management of innovative medical device companies. He founded Check-Cap in 2005 and served as the company's Chief Technology Officer....
-
Advancing the Diagnosis and Treatment of Ductal Carcinoma in Situ (DCIS)
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Leonard Farber, MD, a board-certified Radiation Oncologist, and healthcare executive. Farber is recognized for his ability to identify ground-breaking technologies and position them for success in clinical practice. He…
more -
C3 – Looking for Ideas Beyond Medicine to Change Cancer Care
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Anthony Yanni, M.D., Senior Vice President, patient-centricity at Astellas. In this role, Yanni is responsible for leading the development and execution of Astellas’ global patient-centricity strategy. To understand patient...
-
A Non-Invasive Blood Test Designed to Advance Infectious Disease Diagnostics
In this episode of The Onco’Zine Brief Peter Hofland, Ph.D., talks with Tim Blauwkamp, Ph.D., Chief Scientific Officer and co-founder of Karius. Karius, based in Redwood City, CA, has developed a non-invasive liquid biopsy, a blood test, called the Karius Test®. The test is based on…
more -
Diagnosed with a Rare Cancer During the COVID-19 Pandemic? What Now?
In this edition of The Onco’Zine Brief, Peter Hofland, Ph.D., talks with Vince McRuiz and Margo Shoup, MD, FACS. Margo Shoup is a nationally recognized surgical oncologist who specializes in gastrointestinal cancers and sarcomas. She is also the senior vice president, and system chair of the...
-
Transforming Cell Therapy Manufacturing by “Squeezing” Cells: An Interview with Armon Sharei
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Armon Sharei, Ph.D. Chief Executive Officer of SQZ Biotech, about the development and manufacturing of cell therapies. Traditionally, the foundation of cancer treatment included surgery, chemotherapy, and radiation therapy.…
more -
ASCO 2020: New Developments in the Treatment of Hard to Treat Cancers
In this edition of The Onco’Zine Brief Peter Hofland, Ph.D. talks with Christian Massacesi, MD, Senior Vice President, Head of Late Development Oncology R&D at AstraZeneca and with Jeffrey Skolnik, MD, Vice President, Clinical Development at Inovio Pharmaceuticals about new data and exciting...
-
Advancing CAR T-cell Therapy in Difficult to Treat Cancers: An Interview with Precigen’s Helen Sabzevari
In this edition of The Onco’Zine Brief, Peter Hofland talking with Helen Sabzevari, the president of Precigen. Precigen is a biopharmaceutical company dedicated to the discovery and clinical-stage development of the next generation of gene and cell therapies using precision technology. The…
more -
Sacituzumab Govitecan, a Novel Treatment for Patients with mTNBC
In this episode of The Onco'Zine Brief, Peter Hofland talks with Thorsten Sperber, Global Head Medical Affairs at Immunomedics. Hofland and Sperber talk about sacituzumab govitecan, a novel antibody-drug conjugate. At the time of the interview, the drug was not yet approved, but in the weeks...
-
Sacituzumab Govitecan, a Novel Treatment for Patients with mTNBC
In this episode of The Onco'Zine Brief, Peter Hofland talks with Thorsten Sperber, Global Head Medical Affairs at Immunomedics. Hofland and Sperber talk about sacituzumab govitecan, a novel antibody-drug conjugate. At the time of the interview, the drug was not yet approved, but in the weeks...
-
Finding Community After a Cancer Diagnosis: A Conversation with Terri Conneran
Struggling in the heat and humidity of the summer of 2016, Terri Conneran believed that her asthma was uncontrolled. In August that year, her physician assistant prescribed her a preventive inhaler. That autumn brought the excuse of allergies, plus time for the new inhaler to take effect. By...
-
Susan Rafte: A 25+ Year Survivor of Metastatic Breast Cancer and Patient Advocate
In this episode The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS) held December 10 – 14, 2019 in San Antonio, Texas, Peter Hofland talks with Susan Rafte, a 25+ year survivor of metastatic breast cancer and patient advocate. In 1994, eight and a half months...
-
Candid Conversations on Mets, Sex, and Side Effects: a Panel Discussion With Breast Cancer Oncologists, Women’s Health Experts and Patients
In this edition of The Onco’Zine Brief, recorded during the 42nd San Antonio Breast Cancer Symposium (SABCS), held December 10 - 14, 2019 in San Antonio, Texas, Peter Hofland talks with leading breast cancer experts, and patients about metastatic breast cancer and health related quality of life...
-
Catherine Ivy: A Tireless Advocate for Brain Cancer Patients
In this edition of The Onco’Zine Brief Peter Hofland talks with Catherine Ivy, the Founder and President of the Ben & Catherine Ivy Foundation. The Ben & Catherine Ivy Foundation, established in 2005, is the largest non-government organization supporter of brain tumor - including glioblastoma…
more -
TARDIS - A Simple Blood Draw to Determining a Patient’s Response to Neoadjuvant Therapy
In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Muhammed Murtaza and Dr. Thomas Slavin about liquid biopsies Murtaza is Assistant Professor and co-Director of the Center for Noninvasive Diagnostics at TGen in Phoenix, AZ, and Dr. Slavin is Assistant Clinical Professor,...
-
How does Checkpoint Inhibitor Therapy Work when there’s no Checkpoint Expressed on a Patient's Cancer
Today in The Onco’Zine Brief Peter Hofland talks with Dr. Michael Caligiuri and Deana and Steve Campbell Physician-in-Chief Distinguished Chair, President of City of Hope National Medical Center in Los Angeles, California, and Dr. Jianhua Yu, professor in the Department of Hematology &...
-
BCAN's Mission to Increase Public Awareness, Advance Bladder Cancer Research and Support Patients
Today in The Onco’Zine Brief Peter Hofland talks with Diane Zipursky Quale. Together with her late husband John Quale, Diane, who holds a BA from Stanford University and a JD from the National Law Center, George Washington University, is Co-Founder and Director of the Bladder Cancer Advocacy...
-
Finding Aswers and Improving Patient Care - How Genetic Tests can be Helpful (Part 2)
In this edition of The Onco’Zine Brief Peter Hofland talks with Laura Panos Smith, a certified genetic counselor and vice president of commercial operations at Ambry Genetics. Ms. Smith leads a large team responsible for the implementation of key strategic initiatives for Ambry Genetics. This...
-
Finding Aswers and Improving Patient Care - How Genetic Tests can be Helpful (Part 1)
In this edition of The Onco’Zine Brief Peter Hofland talks with Holly LaDuca, a certified genetic counselor and manager of clinical Research oncology at Ambry Genetics. Identifying an individual’s genetic information is nothing new. And while, over the last decades, most people have become…
more -
ASCO 2019: Form Biomarker Discovery to Photo-Immunotherapy
In this episode of the Onco’Zine Brief Peter Hofland reports from the 2019 annual meeting of the American Society of Clinical Oncology – ASCO – which was held May 31st – June 4th, 2019. Hofland talks with: - Dr. Hartmut Juhl, the Chief Executive Officer of Indivumed, a physician-led, integrated...
-
ASCO 2019: Supportive Care and Developments in Gynecological Cancer
In this episode of The Onco’Zine Brief, recorded during the annual meeting of the American Society of Clinical Oncology, ASCO, being held May 31 – June 4, 2019, Peter Hofland talks with Lee Schwartzberg MD, FACP, is a Medical Oncologist and Hematologist at West Cancer Center, Germantown, TN, and...
-
ASCO 2019: The Courage and Expertese to Outsmarting Cancer
In this episode of The Onco’Zine Brief Peter Hofland report from the annual meeting of the American Society of Clinical Oncology – ASCO – which was held May 31st – June 4th, 2019. The American Society of Clinical Oncology is the world's leading professional organization for physicians and…
more -
Patients Taking Back Control of their Own Healthcare Information
This week The Onco’Zine Brief comes from Chicago, Illinois and the annual meeting of the American Society of Clinical Oncology (ASCO) being held May 31 – June 4, 2019. In this episode Peter Hofland talks with a Eugene Luskin, Chief Executive Officer of Redmond, Washington-based Vyrty. As part of…
more -
Beyond the Emergence of Targeted Therapies and the Treatment of Bladder Cancer
This week The Onco’Zine Brief comes from Chicago, Illinois and the annual meeting of the American Society of Clinical Oncology (ASCO) being held May 31 – June 4, 2019. In this episode Peter Hofland talks with a Adil Akhtar, MD, an Oncologist and Palliative Care Expert, Associate Professor,...
-
Immuno-Oncology: Augmenting the Immune System’s Natural Ability to See and Eliminate Cancer
In this edition of The Onco’Zine Brief Peter Hofland talks with Mr. Isaac Israel, the CEO of Kitov Pharma, a pharmaceutical drug development company developing new options to treat osteoarthritis pain and hypertension simultaneously, as well as novel anticancer drugs. The company is developing an...
-
Better Pain Management Improves Health Related Quality of Life (hrQoL)
In this edition of The Onco’Zine Brief Peter Hofland talk with Dr. Lisa Stearns, the founder and medical director of Center for Pain and Supportive Care, in Phoenix, Arizona. An internationally recognized Interventional Pain Specialist, board certified in hospice and palliative medicine and pain...
-
A New Combination Therapy may help Stop Triple Negative Breast Cancer from Spreading
In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Salman Hyder, Professor in Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center at the University of Missouri, in Columbia, Missouri. Together...
-
Improving the Effect of Anti-cancer Radiation and Chemotherapy
In this edition of The Onco’Zine Brief Peter Hofland talks with Greg Van Wyk, Chief Executive Officer and Chief Medical Officer of Noxopharm, a clinical-stage Australian drug development company with offices in Sydney, New York and Hong Kong. The company is developing a number of drug candidates...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Peter Hofland, Ph.D. is the host of The Onco'Zine Brief, a radio show/podcast especially designed for the community of medical and healthcare professionals in oncology and hematology as well as cancer patients, their families, and caregivers. In the show, Hofland talks about the latest researcher, developments, and news in cancer and cancer treatment. They also interview physicians, world-renowned researchers, Key Opinion Leaders/Experts, and Key Stakeholders who share the common objective of preventing cancer, fostering a favorable environment for scientific research, and advocating for equal access to high-quality cancer treatment, and educate cancer patients and their friends and family.
HOSTED BY
Peter Hofland
CATEGORIES
Loading similar podcasts...
Frequently Asked Questions
How many episodes does The Onco'Zine Brief with Peter Hofland have?
The Onco'Zine Brief with Peter Hofland currently has 101 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is The Onco'Zine Brief with Peter Hofland about?
Peter Hofland, Ph.D. is the host of The Onco'Zine Brief, a radio show/podcast especially designed for the community of medical and healthcare professionals in oncology and hematology as well as cancer patients, their families, and caregivers. In the show, Hofland talks about the latest researcher,...
How often does The Onco'Zine Brief with Peter Hofland release new episodes?
The Onco'Zine Brief with Peter Hofland publishes regularly with 101 episodes available. Check the episode list for the typical release schedule.
Where can I listen to The Onco'Zine Brief with Peter Hofland?
You can listen to The Onco'Zine Brief with Peter Hofland on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts The Onco'Zine Brief with Peter Hofland?
The Onco'Zine Brief with Peter Hofland is created and hosted by Peter Hofland.
URL copied to clipboard!